100 Percent Life Opposition, Pembrolizumab [Keytruda], (A202005849)
No Annotations
Alert me when there are new annotations for this document
5 similar patent oppositions
-
100 Percent Life opposition, Bedaquiline, (a202300343 )
Countries: Ukraine Date: 2025
-
100 Percent Life opposition, Pembrolizumab, (a201911790)
Countries: Ukraine Date: 2025
-
100 Percent Life opposition, Delamanid, (a202100047)
Countries: Ukraine Date: 2025
-
100 Percent Life opposition, GS-4182 (LEN prodrug), (a202403104)
Countries: Ukraine Date: 2025
-
100 Percent Life opposition, Bedaquiline, (PCT/EP2016/051545)
Countries: Ukraine Date: 2020